Meeting
2020 Gastrointestinal Cancers Symposium
How do social determinants of health impact timeliness of chemotherapy and survival in patients with metastatic colon cancer? A 12-year study.
Authors
Thejus Thayyil Jayakrishnan
Medcl Coll of Wisconsin, Wauwatosa, WI
Thejus Thayyil Jayakrishnan , Veli Bakalov , Zena Chahine , Gene Grant Finley , Dulabh K. Monga , Rodney E. Wegner
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Anal and Colorectal Cancer
Track
Colorectal Cancer,Anal Cancer
Sub Track
Patient-Reported Outcomes and Real-World Evidence
Citation
J Clin Oncol 38, 2020 (suppl 4; abstr 36)
Abstract #
36
Poster Bd #
B8
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Influence of the localization of the primary tumor in the survival of patients with metastatic colon-rectal cancer treated with bevacizumab.
First Author: Inmaculada Gallego Jimenez Sr.
Poster
2013 Gastrointestinal Cancers Symposium
Comparative analysis of second- and subsequent chemotherapy lines on short and long-term survival of elderly Medicare metastatic colon cancer patients.
First Author: Nader Hanna
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Associations between BMI, morphomics and survival in 528 patients with metastatic pancreatic cancer.
First Author: Valerie Gunchick
Poster
2023 ASCO Quality Care Symposium
Disparities in time to initiation of treatment among patients with metastatic solid tumors in Washington state.
First Author: Catherine R. Fedorenko